Serum 25-hydroxyvitamin D level and acute-phase reaction following initial intravenous bisphosphonate

Journal of Bone and Mineral Research

Volumn 26, Issue 2, 2011, Pages 437-438

  Srivastava, Tarak ^a   Dai, Hongying ^a   Haney, Connie J ^a   Alon, Uri S ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ATORVASTATIN; BISPHOSPHONIC ACID DERIVATIVE; OXYCODONE; PARACETAMOL; PLACEBO;

ACUTE PHASE RESPONSE; FEVER; HUMAN; LETTER; MUSCULOSKELETAL PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL;

ACUTE-PHASE REACTION; ADOLESCENT; CHILD; DIPHOSPHONATES; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PAIN MEASUREMENT; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; VITAMIN D;

EID: 79251525197     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.290     Document Type: Letter

References (5)

1. Srivastava T, Haney CJ, Alon US., Atorvastatin may have no effect on acute phase reaction in children after intravenous bisphosphonate infusion. J Bone Miner Res. 2009; 24: 334-337.
2. Munns CF, Rajab MH, Hong J, et al. Acute phase response and mineral status following low dose intravenous zoledronic acid in children. Bone. 2007; 41: 366-370.
3. Thompson K, Rogers MJ., Statins prevent bisphosphonate-induced ÎÎ T-cell proliferation and activation in vitro. J Bone Miner Res. 2004; 19: 278-288.
4. Hewitt RE, Lissina A, Green AE, Slay ES, Price DA, Sewell AK., The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood ÎÎ T cells in response to aminobisphosphonates is inhibited by statins. Clin Exp Immunol. 2005; 139: 101-111.
5. Bertoldo F, Pancheri S, Zenari S, et al. Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion. J Bone Miner Res. 2010; 25: 447-454.